Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 47 citing articles:

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States
Michele Kohli, Michael Maschio, Kedar Joshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
The impact of Long COVID on Health-Related Quality-of-Life using OpenPROMPT
Oliver Carlile, Andrew Briggs, Alasdair Henderson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
COVID-19-related health utility values and changes in COVID-19 patients and the general population: a scoping review
Zhuxin Mao, Xiao Li, Mark Jit, et al.
Quality of Life Research (2024) Vol. 33, Iss. 6, pp. 1443-1454
Closed Access | Times Cited: 1
Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life
Tigist F. Menkir, Barbara Wanjiru Citarella, Louise Sigfrid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom
Cale Harrison, Rebecca Butfield, Benjamin Yarnoff, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 730-739
Open Access | Times Cited: 1
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2024 vaccines in the United Kingdom
Michele Kohli, Michael Maschio, Amy Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study at a primary care referred outpatient clinic in Helsinki, Finland
Hélène Virrantaus, Helena Liira, Tatiana Posharina, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e072935-e072935
Open Access | Times Cited: 3
Clinical and Economic impact of updated Fall 2023 COVID-19 vaccines in the Immunocompromised Population in Canada
Amy S. Lee, Kavisha Jayasundara, Michele Kohli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Long COVID: Is there a kidney link?
Raymond E. Garrett, Carlos H. Palacio, David Bar‐Or
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Health-Related Quality of Life for Jordanian-Recovered Individuals During Post-COVID-19 Era: A Cross-Sectional Study
Sawsan Abuhammad, Omar F. Khabour, Karem H. Alzoubi, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 1303-1310
Open Access | Times Cited: 2
Coproducing Health Information Materials With Young People: Reflections and Lessons Learned
Alice Faux‐Nightingale, Glenys Somayajula, Charlotte Bradbury, et al.
Health Expectations (2024) Vol. 27, Iss. 3
Open Access
No Association between SARS-CoV-2 Infection and Quality of Life 6- and 12-Months After Infection
Frederick Dun-Dery, Jianling Xie, Kathleen Winston, et al.
Academic Pediatrics (2024), pp. 102536-102536
Open Access
Characteristics and long-term health outcomes of the first domestic COVID-19 outbreak cases in Da Nang, Vietnam: a longitudinal cohort study
Miyuki Tsuruoka, Mai Kim Huynh, Michiko Toizumi, et al.
Research Square (Research Square) (2024)
Open Access
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States
Alon Yehoshua, Manuela Di Fusco, Abby E. Rudolph, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 1569-1582
Open Access
The estimated disease burden of COVID-19 in Japan from 2020 to 2021
Shinya Tsuzuki, Philippe Beutels
Journal of Infection and Public Health (2023) Vol. 16, Iss. 8, pp. 1236-1243
Open Access | Times Cited: 1
Impact of COVID‐19 versus chronic rhinosinusitis/rhinitis associated olfactory dysfunction on health utility and quality of life
Thanh Luong, Sophie S. Jang, Mena Said, et al.
Laryngoscope Investigative Otolaryngology (2022) Vol. 7, Iss. 5, pp. 1299-1307
Open Access | Times Cited: 2
Data-driven COVID-19 policy is more effective than a one-size-fits-all approach
Zoë M McLaren
Med (2022) Vol. 3, Iss. 10, pp. 660-663
Open Access | Times Cited: 1
The estimated disease burden of COVID-19 in Japan from 2020 to 2021
Shinya Tsuzuki, Philippe Beutels
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
The long-term impacts of COVID-19 on confirmed cases at least 12 months post-infection in Wellington, New Zealand: an observational, cross-sectional study
Nethmi Kearns, Neakiry Kivi, Emily Dickinson, et al.
New Zealand medical journal (2023) Vol. 136, Iss. 1578, pp. 77-93
Open Access
Factors Associated with Health-related Quality of Life after Hospitalization for COVID-19 in Diabetic and Non-diabetic Patients: A Cross-sectional Study

Iranian Red Crescent Medical Journal (2023)
Open Access
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Kedar Joshi, Stefan Scholz, Michael Maschio, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management
Olalekan Lee Aiyegbusi
Current Opinion in Neurology (2023)
Closed Access
Previous Page - Page 2

Scroll to top